Sorafenib inhibits cell growth but fails to enhance radio- and chemosensitivity of glioblastoma cell lines

BACKGROUND: Glioblastomas (GBM) are the most common malignant type of primary brain tumor. GBM are intensively treated with surgery and combined radiochemotherapy using X-irradiation and temozolomide (TMZ) but they are still associated with an extremely poor prognosis, urging for the development of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Riedel, Matthias, Struve, Nina, Müller-Goebel, Justus, Köcher, Sabrina, Petersen, Cordula, Dikomey, Ekkehard, Rothkamm, Kai, Kriegs, Malte
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5308705/
https://ncbi.nlm.nih.gov/pubmed/27542273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11328
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars